JP Patent

JP2018012698A — ポリ（ａｄｐ−リボース）ポリメラーゼ（ｐａｒｐ）のジヒドロピリドフタラジノン阻害剤

Assigned to Medivation Technologies LLC · Expires 2018-01-25 · 8y expired

What this patent protects

【課題】新規ポリ（ADPリボース）ポリメラーゼ活性阻害剤の提供。 【解決手段】式（Ｉ）等で表される８，９−ジヒドロ−２Ｈ−ピリド［４，３，２−ｄｅ］フタラジン−３（７Ｈ）−オン化合物。 【選択図】なし

USPTO Abstract

【課題】新規ポリ（ADPリボース）ポリメラーゼ活性阻害剤の提供。 【解決手段】式（Ｉ）等で表される８，９−ジヒドロ−２Ｈ−ピリド［４，３，２−ｄｅ］フタラジン−３（７Ｈ）−オン化合物。 【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number
JP2018012698A
Jurisdiction
JP
Classification
—
Expires
2018-01-25
Drug substance claim
No
Drug product claim
No
Assignee
Medivation Technologies LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.